A detailed history of State Street Corp transactions in Harrow Health, Inc. stock. As of the latest transaction made, State Street Corp holds 715,419 shares of HROW stock, worth $32.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
715,419
Previous 635,372 12.6%
Holding current value
$32.7 Million
Previous $8.41 Million 77.81%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.0 - $21.64 $800,470 - $1.73 Million
80,047 Added 12.6%
715,419 $14.9 Million
Q1 2024

May 15, 2024

BUY
$9.3 - $13.23 $161,187 - $229,302
17,332 Added 2.8%
635,372 $8.41 Million
Q4 2023

Feb 14, 2024

SELL
$8.1 - $16.36 $572,078 - $1.16 Million
-70,627 Reduced 10.26%
618,040 $6.92 Million
Q3 2023

Nov 14, 2023

BUY
$14.03 - $22.08 $1.47 Million - $2.31 Million
104,794 Added 17.95%
688,667 $9.9 Million
Q2 2023

Aug 14, 2023

BUY
$17.37 - $28.08 $8.44 Million - $13.6 Million
485,860 Added 495.71%
583,873 $11.1 Million
Q1 2023

May 15, 2023

BUY
$13.84 - $21.46 $155,008 - $240,352
11,200 Added 12.9%
98,013 $2.07 Million
Q1 2022

May 16, 2022

BUY
$6.77 - $8.66 $30,607 - $39,151
4,521 Added 5.49%
86,813 $592,000
Q3 2021

Nov 15, 2021

BUY
$6.99 - $10.6 $87,375 - $132,500
12,500 Added 17.91%
82,292 $748,000
Q2 2021

Aug 16, 2021

SELL
$6.68 - $11.07 $1.86 Million - $3.08 Million
-278,631 Reduced 79.97%
69,792 $648,000
Q1 2021

May 17, 2021

SELL
$6.26 - $11.03 $901 - $1,588
-144 Reduced 0.04%
348,423 $2.35 Million
Q4 2020

Feb 16, 2021

BUY
$4.76 - $6.93 $404,604 - $589,056
85,001 Added 32.25%
348,567 $2.39 Million
Q3 2020

Nov 10, 2020

BUY
$4.71 - $7.36 $39,578 - $61,846
8,403 Added 3.29%
263,566 $1.47 Million
Q2 2020

Aug 14, 2020

BUY
$3.61 - $6.47 $921,138 - $1.65 Million
255,163 New
255,163 $1.33 Million

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.24B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.